BioLife Solutions Granted European Biopreservation Patent
News Dec 10, 2008
BioLife Solutions, Inc. has announced that it has been granted a European patent for an application that includes claims related to protecting cells from injury and death caused by cold temperatures used in biopreservation. The patent titled, “Inclusion of Apoptotic Regulators in Solutions for Cell Storage at Low Temperature,” was previously granted US patent protection.
Mike Rice, BioLife’s chairman and CEO, noted that the new patent expands the protections of the Company’s key intellectual property related to regulating the biologic process of apoptosis in response to the accumulated stress due to exposure to hypothermic and freezing temperatures.
The new patent is a direct result of BioLife’s ongoing effort to increase the value of its intellectual property portfolio and enable additional product and licensing revenue streams for BioLife, he added.
“We’ve repeatedly shown via numerous internal and customer validations that our products better protect cells and tissues from the harmful necrotic and apoptotic effects of hypothermic storage, freezing, and thawing, and as a result, can extend the shelf life and improve the post preservation recovery, viability, and functional yield of both biologic source material as well as isolated cells,” Rice said, adding that the Company has submitted several additional patent applications during 2008.